LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation,(OTCBB:HEMA) a leader in cell and tissue collection, processing, and cell therapy solutions, today announced that it achieved its Q2 marketing goals of driving greater awareness of its capabilities to potential new customers, as well as maintaining and developing deeper collaborations with current customers and partners. At the American Association for Cancer Research meeting in April, HemaCare delivered a record number of new customer signups for inclusion in its email channel with researchers and developers of diagnostics and cancer therapies.
